New Ray Medicine International Holding (HKSE:06108) Selling and Marketing Expense : HK$11.39 Mil (TTM As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is New Ray Medicine International Holding Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. New Ray Medicine International Holding's Selling and Marketing Expense for the six months ended in Jun. 2024 was HK$4.88 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2024 was HK$11.39 Mil.

New Ray Medicine International Holding Selling and Marketing Expense Historical Data

The historical data trend for New Ray Medicine International Holding's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Ray Medicine International Holding Selling and Marketing Expense Chart

New Ray Medicine International Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Selling and Marketing Expense

Get a 7-Day Free Trial

16.68

10.53

12.63

19.24

14.07

New Ray Medicine International Holding Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Selling and Marketing Expense	Get a 7-Day Free Trial															9.82	9.43	7.55	6.52	4.88

New Ray Medicine International Holding Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$11.39 Mil.

New Ray Medicine International Holding Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of New Ray Medicine International Holding's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

New Ray Medicine International Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » New Ray Medicine International Holding Ltd (HKSE:06108) » Definitions » Selling and Marketing Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Dangui Road, B-C, 37th Floor, Dikai International Center, Hangzhou, CHN

Website

http://www.newraymedicine.com

New Ray Medicine International Holding Ltd is engaged in the trading and distribution of pharmaceutical products in the People's Republic of China. The company's segments include the Distribution and trading of pharmaceutical products and the Provision of marketing and promotion services. Distribution and trading of pharmaceutical products consist of Injection drugs and generate a majority of revenue for the company.

Executives

Dai Xiaosong
Eagle Amber Holdings Limited
Chu Xueping	2201 Interest of corporation controlled by you
Qian Shenglei	2101 Beneficial owner
Zhang Jiang	2201 Interest of corporation controlled by you
Yang Fang	2202 Interest of your spouse
Zhou Ling	2101 Beneficial owner

New Ray Medicine International Holding Headlines

No Headlines